Yukinobu Watanabe Masahiro Ogawa Yu Tamura Seiichiro Suda Masahiro Kaneko Mariko Kumagawa Midori Hirayama Naoki Matsumoto Toshiki Yamamoto Mitsuhiko Moriyama
10.1177/23247096211058489
J Investig Med High Impact Case Rep
2021 Jan-Dec;9:23247096211058489.
hepatocellular carcinoma atezolizumab bevacizumab immune checkpoint inhibitor pseudoprogression
CC BY-NC
https://pubmed.ncbi.nlm.nih.gov/34845921/
Carcinoma, Hepatocellular / drug therapy Chemoembolization, Therapeutic Liver Neoplasms / drug therapy
Carcinoma, Hepatocellular / drug therapy Chemoembolization, Therapeutic Liver Neoplasms / drug therapy Case Reports Aged Antibodies, Monoclonal, Humanized Antineoplastic Combined Chemotherapy Protocols / therapeutic use Bevacizumab / therapeutic use Humans Male Antibodies, Monoclonal, Humanized Bevacizumab atezolizumab
PMC8637399
34845921
A Case of Pseudoprogression in Hepatocellular Carcinoma Treated With Atezolizumab Plus Bevacizumab
2021